Ontruzant 440 mg

Ontruzant 440 mg is a powder for solution used in intravenous therapy. It contains trastuzumab, a monoclonal antibody for targeted treatment. This medication is commonly used in cancer therapy.

Ontruzant 440 mg is primarily used in the treatment of certain types of cancer. It works by targeting specific proteins on cancer cells, helping to slow or stop their growth. This medication is often used in combination with other cancer treatments.

Common effects of Ontruzant 440 mg may include fatigue, nausea, and injection site reactions. Some individuals may experience more severe side effects, such as fever or difficulty breathing. Always consult a healthcare provider for personalized advice.

Ontruzant 440 mg should be handled with care and administered by a healthcare professional. It is important to follow proper storage and preparation guidelines. Inform your healthcare provider about any allergies or medical conditions before use.

Ontruzant 440 mg may interact with other medications, including those that affect the immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Always follow the advice of a healthcare professional.